Swedish Orphan Biovitrum AB (publ) ( BIOVF) - Key Metrics
BIOVF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | ? | ? | ? | ? |
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $22.65 | $5.39 | $8.63 | $8.61 |
| 2025Q3 | $22.56 | -$8.40 | $5.34 | $5.32 |
| 2025Q2 | $17.96 | $1.85 | $4.21 | $2.99 |
BIOVF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | ? | ? |
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 15.43 |
| 2025Q3 | ? | -8.54 |
| 2025Q2 | ? | 38.94 |
BIOVF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.98% | ? |
| 2026Q1 | 0.67% | ? |
| 2025Q4 | 2.64% | ? |
| 2025Q3 | 1.87% | ? |
| 2025Q2 | 1.08% | ? |
BIOVF
Price: $49.03
52 week price:
Earnings Per Share: 0.40 USD
P/E Ratio: 122.57
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 17.1 billion